April 12, 2013
Irish biopharmaceutical giant Shire PLC lodged its latest bid Thursday to maintain patent protection over the blockbuster attention deficit hyperactivity disorder treatment Adderall XR, suing Neos Therapeutics Inc. in Texas federal court for applying to produce a competing drug.